Origin Medical
Entrepreneur First '20Singapore, SG · Founded 2020 · 18 employees on LinkedIn · 1 known investors
Find your way into Origin Medical
437 people in our graph share verified history with the Origin Medical team — schools, employers, funds. One of them is your warm intro.
Origin Medical develops a real-time AI assistant for prenatal ultrasound examinations that aims to shorten exam times, standardize workflows, and reduce errors. It serves sonographers, reading physicians, health systems, and private practices to improve the quality and consistency of prenatal scans and patient care.
Also known as OMEA · Origin Health · Origin Medical Research Lab
Founders & leadership
Origin Medical was founded in 2020 by Jens Thang and Sripad Devalla.
Investors · 1
Company profile
researched Aug 2026Origin Medical, formerly Origin Health, develops artificial intelligence software for prenatal ultrasound. Its flagship product, the Origin Medical EXAM ASSISTANT (OMEA), applies real-time AI on top of routine pregnancy ultrasound to help maternal health practitioners acquire diagnostic-quality images and interpret examinations across all stages of pregnancy. The company positions the product as a prenatal workflow assistant that shortens exam times, standardizes practice workflows and reduces human-centric errors, and states it is configurable to each practice's workflow requirements.
The company frames its mission as advancing maternal health equity by improving access to quality prenatal care with AI, citing the subjectivity of ultrasound imaging and interpretation, variability in care quality, and a global shortage of maternal healthcare providers, particularly in rural areas. Its publications library lists clinical validation studies (2021-2022) covering automated detection of the "lemon sign" and choroid plexus cysts on fetal cranial sonograms, quantification and screening of suspected ventriculomegaly, automated fetal brain measurements and caliper placement, device-independent segmentation of sonographic fetal brain structures, and multi-reader pilot/feasibility studies on 2D fetal neurosonogram video loops. A February 2025 whitepaper reports that OMEA cuts scan time by 33% while improving completion rate and capacity and providing ergonomic relief for sonographers.
Origin Medical operates an internal research arm, Origin Medical Research Lab, launched in May 2024 and headquartered in Bengaluru, Karnataka, India, intended to concentrate AI and healthcare research talent and infrastructure.
Founding story
A third-party company database lists Sripad Krishna Devalla and Jens Thang as founders and gives a founding year of 2019, which conflicts with the internally held founding year of 2020. Sources do not otherwise describe the founding circumstances.
Business model
The company supplies AI software that layers onto routine prenatal ultrasound workflows and is sold to clinical providers, including health systems and private practices; sources do not describe pricing, contract structures or distribution arrangements.
Traction
Publicly documented traction consists of a portfolio of clinical validation and pilot studies dated 2021-2022, a February 2025 whitepaper reporting a 33% reduction in scan time along with improved completion rate and capacity, and a first exhibitor appearance at ACOG's 2025 Annual Clinical and Scientific Meeting. A third-party profile lists headcount of 10-50 and $7.21 million raised across two rounds, with a $550,000 Series A dated 30 July 2025. No customer counts, revenue or deployment volumes are disclosed in the sources.
Latest developments
The most recent developments in the sources are the February 2025 OMEA whitepaper, the May 2025 announcement of the company's ACOG ACSM 2025 exhibit and featured presentation, and a third-party listing of a $550,000 Series A round dated 30 July 2025.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company describes itself as a pioneer in advancing AI in prenatal care. A third-party company database lists Exo, EchoNous, iSono Health, AISAP and Emagine Solutions Technology among its competitors in AI-enabled ultrasound.
Origin Medical emphasizes real-time assistance during the exam itself (acquisition plus interpretation) rather than post-hoc reading, workflow fit to individual practices, and a body of peer-review-style clinical validation and multi-reader pilot studies on fetal neurosonography, supported by an in-house research lab.
Technology
Real-time AI/deep learning applied to 2D prenatal ultrasound imaging, supporting image acquisition guidance, automated segmentation of fetal brain structures, automated caliper placement and biometric measurement, and detection or screening of anomalies such as the lemon sign, choroid plexus cysts and suspected ventriculomegaly. Published validations describe multi-center, multi-device and multi-reader study designs, including device-independent segmentation approaches and clinically relevant biometric constraints used to supervise model training.
Go-to-market
Origin Medical markets directly to clinicians and provider organizations through demo requests and meeting-scheduling forms on its website, and through conference exhibition; in May 2025 it exhibited for the first time at the ACOG Annual Clinical and Scientific Meeting in Minneapolis (booth #347, Innovation Lane) with a featured presentation. It also publishes clinical validation studies, pilot studies and whitepapers as evidence for prospective buyers.
Sonographers, reading physicians, health systems and private practices delivering prenatal ultrasound care, in both rural and urban settings.
Geography
Company press releases state Origin Medical is headquartered in Cambridge, Massachusetts, USA, and that its Origin Medical Research Lab is headquartered in Bengaluru, Karnataka, India. A third-party profile also places the company in Cambridge, United States. Commercial activity described in the sources targets the U.S. market, with mission language referencing global reach.
History
The company previously operated as Origin Health, under which name it won the Affordable Care Award at MICCAI Startup Village 2021 (October 2021), joined the TMC Innovation Accelerator (January 2022) and was featured at the CDL Super Session 2022 (June 2022). It rebranded to Origin Medical in April 2024, launched Origin Medical Research Lab in Bengaluru in May 2024, and expanded its board in June 2024 with Stephen Bruso and Mike Butler.
Risks & controversies
No controversies are reported in the sources. Data limitations exist: a third-party aggregator reports a 2019 founding year and Cambridge, Massachusetts headquarters, differing from the internally recorded 2020 founding and Singapore headquarters, and reports a $7.21 million total against a $550,000 Series A without naming investors. Executive titles also differ between sources: the company's about page lists Sripad Krishna Devalla as co-founder and CEO and Jens Thang as co-founder and COO, while its 2024-2025 press releases identify Thang as co-founder and CEO and Devalla as co-founder and CTO.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Founder mafia
2 people who came through Origin Medical went on to found or lead other companies.
Timeline · 8
launches, deals, and filingsOrigin Medical announced its debut as an exhibitor at the ACOG Annual Clinical and Scientific Meeting, May 16-18, 2025 at the Minneapolis Convention Center, exhibiting at booth #347 in the Innovation Lane with a featured presentation on May 16, and showing Origin Medical EXAM ASSISTANT.
Whitepaper titled "Origin Medical EXAM ASSISTANT (OMEA) Cuts Scan Time by 33%, Improves Completion Rate and Capacity, while providing Ergonomic Relief for Sonographers" listed in the company's evidence library.
Origin Medical added Stephen Bruso of Morningside Ventures and Mike Butler, former President of Providence Health, to its Board of Directors.
Origin Medical announced the launch of Origin Medical Research Lab, a research arm headquartered in Bengaluru, Karnataka, India, focused on AI and healthcare research for prenatal care.
The company announced a rebrand from Origin Health to Origin Medical, including a new logo whose Morse code elements represent the initials O, M, A and I (Origin, Medical, Artificial, Intelligence). The announcement identifies the company as headquartered in Cambridge, Massachusetts, USA.
News listing states Origin Health became part of the TMC Innovation Accelerator to advance prenatal care.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Origin Medicaloriginmedical.ai · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Origin Medical do?
- Origin Medical builds real-time AI software that assists clinicians in acquiring and interpreting prenatal ultrasound exams.
- Who founded Origin Medical?
- Origin Medical was founded by Jens Thang, Sripad Devalla in 2020.
- Who are Origin Medical's investors?
- Origin Medical's investors include Entrepreneur First.
- Where is Origin Medical headquartered?
- Origin Medical is headquartered in Singapore, SG.